- Japan（Japanese / English）
- Global
- MBL TOP
- MBL site search
Close
The price is only for customers living in Japan.
For customer living outside of Japan, please visit the Global page.
For customer living outside of Japan, please visit the Global page.
HOME > Product search results
Searched by
Category - cancer
Product（476）
Refine your search
[+]Animal species
[+]Category
[+]Conjugate
[+]MHC Allele
[+]Research area
[+]Tools
[+]Brands
[+]Availability (in Japan)
| Clip | Code No. | Product | Data | ||||
|---|---|---|---|---|---|---|---|
| Data
Sheet |
Category | Conjugate | MHC Allele | Size | Price | Availability | |
| Sequence | Location (aa) | Storage
temp. |
|||||
|
|
|||||||
|
TC-0113-2 |
HLA-A*02:01 hTERT Tetramer-YLFFYRKSV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| YLFFYRKSV | ４°C | ||||||
|
|
TC-0136-2 |
HLA-A*02:01 p53 Tetramer-GLAPPQHLIRV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| GLAPPQHLIRV | 187-197 | ４°C | |||||
|
|
TC-0157-1 |
HLA-A*02:01 p53 Tetramer-RMPEAAPPV-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| RMPEAAPPV | 65-73 | ４°C | |||||
|
|
TC-0169-1 |
HLA-A*02:01 BCR-ABL Tetramer-GVRGRVEEI-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| GVRGRVEEI | ４°C | ||||||
|
|
TC-0110-4 |
HLA-A*02:01 Mesothelin Tetramer-SLLFLLFSL-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| SLLFLLFSL | ４°C | ||||||
|
|
TC-0136-4 |
HLA-A*02:01 p53 Tetramer-GLAPPQHLIRV-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| GLAPPQHLIRV | 187-197 | ４°C | |||||
|
|
TC-0152-4 |
HLA-A*02:01 p53 Tetramer-KLCPVQLWV-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| KLCPVQLWV | 139-147 | ４°C | |||||
|
|
TS-M078-4 |
HLA-A*02:01 MAGE-A10 Tetramer-GLYDGMEHL-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥219,500 |
0 (Contact us) |
|
| GLYDGMEHL | ４°C | ||||||
|
|
TC-0112-2 |
HLA-A*02:01 Mesothelin Tetramer-VLPLTVAEV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| VLPLTVAEV | ４°C | ||||||
|
|
TC-0110-1 |
HLA-A*02:01 Mesothelin Tetramer-SLLFLLFSL-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 | 1-9 | |
| SLLFLLFSL | ４°C | ||||||
|
|
TC-0153-4 |
HLA-A*02:01 MUC1 Tetramer-LLLTVLTVV-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| LLLTVLTVV | 13-21 | ４°C | |||||
|
|
TS-M070-2 |
HLA-A*02:01 MAGE-A1 Tetramer-KVLEYVIKV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥219,500 |
0 (Contact us) |
|
| KVLEYVIKV | 278-286 | ４°C | |||||
|
|
TC-0150-4 |
HLA-A*02:01 hTERT Tetramer-GLLGASVLGL-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| GLLGASVLGL | 674-683 | ４°C | |||||
|
|
TC-0151-4 |
HLA-A*02:01 BA46 Tetramer-GLQHWVPEL-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| GLQHWVPEL | 97-106 | ４°C | |||||
|
|
TC-0112-1 |
HLA-A*02:01 Mesothelin Tetramer-VLPLTVAEV-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| VLPLTVAEV | ４°C | ||||||
|
|
TC-0150-2 |
HLA-A*02:01 hTERT Tetramer-GLLGASVLGL-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| GLLGASVLGL | 674-683 | ４°C | |||||
|
|
TC-0152-1 |
HLA-A*02:01 p53 Tetramer-KLCPVQLWV-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| KLCPVQLWV | 139-147 | ４°C | |||||
|
|
TC-0169-4 |
HLA-A*02:01 BCR-ABL Tetramer-GVRGRVEEI-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| GVRGRVEEI | ４°C | ||||||
|
|
TS-M076-4 |
HLA-A*02:01 MAGE-A3 271-279 Tetramer-FLWGPRALV-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥219,500 |
0 (Contact us) |
|
| FLWGPRALV | 271-279 | ４°C | |||||
|
|
TC-0152-2 |
HLA-A*02:01 p53 Tetramer-KLCPVQLWV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| KLCPVQLWV | 139-147 | ４°C | |||||
|
|
TS-M081-1 |
HLA-A*02:01 p53 Tetramer-LLGRNSFEV-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥219,500 | 1-9 | |
| LLGRNSFEV | 264-272 | ４°C | |||||
|
|
TC-5116-1 |
H-2Kb RPL18 Neoepitope Tetramer-KILTFDRL-PE |
|
||||
|
|
cancer | PE | H-2Kb | 50 tests | ￥209,000 |
0 (Contact us) |
|
| KILTFDRL | ４°C | ||||||
|
|
TS-M518-1 |
T-Select H-2Db CEA Tetramer-EAQNTTYL-PE |
|
||||
|
|
cancer | PE | H-2Db | 50 tests | ￥219,500 |
0 (Contact us) |
|
| EAQNTTYL | 526-533 | ４°C | |||||
|
|
TS-M079-2 |
HLA-A*02:01 SSX-2 Tetramer-KASEKIFYV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥219,500 |
0 (Contact us) |
|
| KASEKIFYV | 41-49 | ４°C | |||||
|
|
TS-M544-1 |
H-2Kd JAK1 Tetramer-SYFPEITHI-PE |
|
||||
|
|
cancer | PE | H-2Kd | 50 tests | ￥219,500 |
0 (Contact us) |
|
| SYFPEITHI | 367-375 | ４°C | |||||
|
|
TS-M016-2 |
T-Select HLA-A*02:01 WT1126-134 Tetramer-RMFPNAPYL-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥219,500 | 1-9 | |
| RMFPNAPYL | 126-134 | ４°C | |||||
|
|
TC-5116-2 |
H-2Kb RPL18 Neoepitope Tetramer-KILTFDRL-APC |
|
||||
|
|
cancer | APC | H-2Kb | 50 tests | ￥209,000 |
0 (Contact us) |
|
| KILTFDRL | ４°C | ||||||
|
|
TS-M544-2 |
H-2Kd JAK1 Tetramer-SYFPEITHI-APC |
|
||||
|
|
cancer | APC | H-2Kd | 50 tests | ￥219,500 |
0 (Contact us) |
|
| SYFPEITHI | 367-375 | ４°C | |||||
|
|
TS-M011-4 |
HLA-A*02:01 NY-ESO-1 Tetramer-SLLMWITQC-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥219,500 | 1-9 | |
| SLLMWITQC | 157-165 | ４°C | |||||
|
|
TS-M095-2 |
HLA-A*02:01 PP2A Tetramer-SLLPAIVEL-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥219,500 |
0 (Contact us) |
|
| SLLPAIVEL | 402-410 | ４°C | |||||
|
|
TC-5114-1 |
H-2Db REPS1 Neoepitope Tetramer-AQLANDVVL-PE |
|
||||
|
|
cancer | PE | H-2Db | 50 tests | ￥209,000 |
0 (Contact us) |
|
| AQLANDVVL | ４°C | ||||||
|
|
TC-0140-1 |
HLA-A*24:02 GPC3 Tetramer-EYILSLEEL-PE |
|
||||
|
|
cancer | PE | A*24:02 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| EYILSLEEL | 298-306 | ４°C | |||||
|
|
TS-M075-4 |
HLA-A*02:01 MAGE-A3 112-120 Tetramer-KVAELVHFL-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥219,500 |
0 (Contact us) |
|
| KVAELVHFL | 112-120 | ４°C | |||||
|
|
TC-0140-4 |
HLA-A*24:02 GPC3 Tetramer-EYILSLEEL-BV421 |
|
||||
|
|
cancer | BV421 | A*24:02 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| EYILSLEEL | 298-306 | ４°C | |||||
|
|
TC-0167-4 |
HLA-A*24:02 LY6K Tetramer-RYCNLEGPPI-BV421 |
|
||||
|
|
cancer | BV421 | A*24:02 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| RYCNLEGPPI | 177-186 | ４°C | |||||
|
|
TS-M505-4 |
H-2Db human gp 100 Tetramer-KVPRNQDWL-BV421 |
|
||||
|
|
cancer | BV421 | H-2Db | 50 tests | ￥219,500 |
0 (Contact us) |
|
| KVPRNQDWL | 25-33 | ４°C | |||||
|
|
TC-5108-2 |
H-2Db Survivin Tetramer-ATFKNWPFL-APC |
|
||||
|
|
cancer | APC | H-2Db | 50 tests | ￥209,000 |
0 (Contact us) |
|
| ATFKNWPFL | 20-28 | ４°C | |||||
|
|
TC-0153-1 |
HLA-A*02:01 MUC1 Tetramer-LLLTVLTVV-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| LLLTVLTVV | 13-21 | ４°C | |||||
|
|
TC-0139-4 |
HLA-A*24:02 PSA Tetramer-CYASGWGSI-BV421 |
|
||||
|
|
cancer | BV421 | A*24:02 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| CYASGWGSI | 153-161 | ４°C | |||||
|
|
TS-M562-4 |
H-2Kb mTERT Tetramer-VGRNFTNL-BV421 |
|
||||
|
|
cancer | BV421 | H-2Kb | 50 tests | ￥219,500 |
0 (Contact us) |
|
| VGRNFTNL | ４°C | ||||||
|
|
TC-5114-4 |
H-2Db REPS1 Neoepitope Tetramer-AQLANDVVL-BV421 |
|
||||
|
|
cancer | BV421 | H-2Db | 50 tests | ￥209,000 |
0 (Contact us) |
|
| AQLANDVVL | ４°C | ||||||
|
|
TC-0157-2 |
HLA-A*02:01 p53 Tetramer-RMPEAAPPV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| RMPEAAPPV | 65-73 | ４°C | |||||
|
|
TC-0166-2 |
HLA-A*03:01 gp100 Tetramer-ALLAVGATK-APC |
|
||||
|
|
cancer | APC | A*03:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| ALLAVGATK | ４°C | ||||||
|
|
TS-0019-4C |
HLA-A*02:01 Tyrosinase Tetramer-YMDGTMSQV-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥219,500 |
0 (Contact us) |
|
| YMDGTMSQV | ４°C | ||||||
|
|
TC-0105-4 |
HLA-A*03:01 hTERT Tetramer-KLFGVLRLK-BV421 |
|
||||
|
|
cancer | BV421 | A*03:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| KLFGVLRLK | ４°C | ||||||
|
|
TC-5105-4 |
H-2Kd MAGE-A3 Tetramer-SYVKVLHHM-BV421 |
|
||||
|
|
cancer | BV421 | H-2Kd | 50 tests | ￥209,000 |
0 (Contact us) |
|
| SYVKVLHHM | ４°C | ||||||
|
|
TC-0136-1 |
HLA-A*02:01 p53 Tetramer-GLAPPQHLIRV-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| GLAPPQHLIRV | 187-197 | ４°C | |||||
|
|
TC-0126-4 |
HLA-A*01:01 Tyrosinase Tetramer-KSDICTDEY-BV421 |
|
||||
|
|
cancer | BV421 | A*01:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| KSDICTDEY | 243-251 | ４°C | |||||
|
|
TC-0129-2 |
HLA-B*35:01 NY-ESO-1 Tetramer-MPFATPMEA-APC |
|
||||
|
|
cancer | APC | B*35:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| MPFATPMEA | 94-102 | ４°C | |||||
|
|
TS-0015-4C |
HLA-A*02:01 Her-2/neu E75 Tetramer-KIFGSLAFL-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥219,500 |
0 (Contact us) |
|
| KIFGSLAFL | 369-377 | ４°C | |||||
|
|
TC-5102-2 |
H-2Kb Survivin Tetramer-MFFCFKEL-APC |
|
||||
|
|
cancer | APC | H-2Kb | 50 tests | ￥209,000 |
0 (Contact us) |
|
| MFFCFKEL | ４°C | ||||||
|
|
TC-0105-2 |
HLA-A*03:01 hTERT Tetramer-KLFGVLRLK-APC |
|
||||
|
|
cancer | APC | A*03:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| KLFGVLRLK | ４°C | ||||||
|
|
TC-0155-4 |
HLA-A*02:01 Survivin Tetramer-LTLGEFLKL-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| LTLGEFLKL | 96-104 | ４°C | |||||
|
|
TC-0120-1 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTV-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| YLEPGPVTV | ４°C | ||||||
|
|
TC-0167-1 |
HLA-A*24:02 LY6K Tetramer-RYCNLEGPPI-PE |
|
||||
|
|
cancer | PE | A*24:02 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| RYCNLEGPPI | 177-186 | ４°C | |||||
|
|
TS-M070-4 |
HLA-A*02:01 MAGE-A1 Tetramer-KVLEYVIKV-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥219,500 |
0 (Contact us) |
|
| KVLEYVIKV | 278-286 | ４°C | |||||
|
|
TC-0157-4 |
HLA-A*02:01 p53 Tetramer-RMPEAAPPV-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| RMPEAAPPV | 65-73 | ４°C | |||||
|
|
TC-0113-4 |
HLA-A*02:01 hTERT Tetramer-YLFFYRKSV-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| YLFFYRKSV | ４°C | ||||||
|
|
TC-0159-4 |
HLA-A*02:01 p53 Tetramer-SLPPPGTRV-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| SLPPPGTRV | 149-157 | ４°C | |||||
|
|
TC-0164-1 |
HLA-A*02:01 EZH2 Tetramer-YMCSFLFNL-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| YMCSFLFNL | 666-674 | ４°C | |||||
|
|
TS-0016-2 |
HLA-A*02:01 Her-2/neu Tetramer-RLLQETELV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥219,500 |
0 (Contact us) |
|
| RLLQETELV | 689-697 | ４°C | |||||
|
|
TC-0114-2 |
HLA-A*02:01 hTERT Tetramer-YLQVNSLQTV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| YLQVNSLQTV | ４°C | ||||||
|
|
TC-0128-2 |
HLA-A*02:01 hTERT Tetramer-ALLTSRLRFI-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| ALLTSRLRFI | 615-624 | ４°C | |||||
|
|
TC-0156-4 |
HLA-A*02:01 LIVIN Tetramer-QLCPICRAPV-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| QLCPICRAPV | 175-184 | ４°C | |||||
|
|
TC-0128-1 |
HLA-A*02:01 hTERT Tetramer-ALLTSRLRFI-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| ALLTSRLRFI | 615-624 | ４°C | |||||
|
|
TC-0114-4 |
HLA-A*02:01 hTERT Tetramer-YLQVNSLQTV-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| YLQVNSLQTV | ４°C | ||||||
|
|
TC-0132-2 |
HLA-A*02:01 topo II Tetramer-FLYDDNQRV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| FLYDDNQRV | 828-836 | ４°C | |||||
|
|
TC-0159-1 |
HLA-A*02:01 p53 Tetramer-SLPPPGTRV-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| SLPPPGTRV | 149-157 | ４°C | |||||
|
|
TS-0016-4 |
HLA-A*02:01 Her-2/neu Tetramer-RLLQETELV-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥219,500 |
0 (Contact us) |
|
| RLLQETELV | 689-697 | ４°C | |||||
|
|
TC-0113-1 |
HLA-A*02:01 hTERT Tetramer-YLFFYRKSV-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| YLFFYRKSV | ４°C | ||||||
|
|
TC-0161-1 |
HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| VLAGGFFLL | 27-38 | ４°C | |||||
|
|
TC-0132-1 |
HLA-A*02:01 topo II Tetramer-FLYDDNQRV-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| FLYDDNQRV | 828-836 | ４°C | |||||
|
|
TS-M072-2 |
HLA-A*02:01 MAGE-A2 Tetramer-YLQLVFGIEV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥219,500 |
0 (Contact us) |
|
| YLQLVFGIEV | 157-166 | ４°C | |||||
|
|
TC-0127-2 |
HLA-A*02:01 PSCA Tetramer-AILALLPAL-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| AILALLPAL | 105-133 | ４°C | |||||
|
|
TC-0150-1 |
HLA-A*02:01 hTERT Tetramer-GLLGASVLGL-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| GLLGASVLGL | 674-683 | ４°C | |||||
|
|
TC-0110-2 |
HLA-A*02:01 Mesothelin Tetramer-SLLFLLFSL-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| SLLFLLFSL | ４°C | ||||||
|
|
TC-0153-2 |
HLA-A*02:01 MUC1 Tetramer-LLLTVLTVV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| LLLTVLTVV | 13-21 | ４°C | |||||
|
|
TC-0164-4 |
HLA-A*02:01 EZH2 Tetramer-YMCSFLFNL-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| YMCSFLFNL | 666-674 | ４°C | |||||
|
|
TS-M076-2 |
HLA-A*02:01 MAGE-A3 271-279 Tetramer-FLWGPRALV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥219,500 | 1-9 | |
| FLWGPRALV | 271-279 | ４°C | |||||
|
|
TC-0159-2 |
HLA-A*02:01 p53 Tetramer-SLPPPGTRV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| SLPPPGTRV | 149-157 | ４°C | |||||
|
|
TS-M107-4 |
HLA-A*02:01 PAP 299-307 Tetramer-ALDVYNGLL-BV421 |
|
||||
|
|
cancer | BV421 | A*02:01 | 50 tests | ￥219,500 |
0 (Contact us) |
|
| ALDVYNGLL | 299-307 | ４°C | |||||
|
|
TS-M082-2 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTA-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥219,500 |
0 (Contact us) |
|
| YLEPGPVTA | 280-288 | ４°C | |||||
|
|
TC-8006-1 |
HLA-A*02:01 P53168-176 R175H Tetramer-HMTEVVRHC-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| HMTEVVRHC | 168-176 | ４°C | |||||
|
|
TC-8010-2 |
HLA-A*02:01 KRAS5-14 G12D Tetramer-KLVVVGADGV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| KLVVVGADGV | 5-14 | ４°C | |||||
|
|
TC-8006-2 |
HLA-A*02:01 P53168-176 R175H Tetramer-HMTEVVRHC-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| HMTEVVRHC | 168-176 | ４°C | |||||
|
|
TC-8010-1 |
HLA-A*02:01 KRAS5-14 G12D Tetramer-KLVVVGADGV-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| KLVVVGADGV | 5-14 | ４°C | |||||
|
|
TC-8003-2 |
HLA-A*11:01 KRAS7-16 G12V Tetramer-VVVGAVGVGK-APC |
|
||||
|
|
cancer | APC | A*11:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| VVVGAVGVGK | 7-16 | ４°C | |||||
|
|
TC-8031-1 |
HLA-A*03:01 KRAS7-16 G12D Tetramer-VVVGADGVGK-PE |
|
||||
|
|
cancer | PE | A*03:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| VVVGADGVGK | 7-16 | ４°C | |||||
|
|
TC-8002-1 |
HLA-A*11:01 KRAS8-16 G12D Tetramer-VVGADGVGK-PE |
|
||||
|
|
cancer | PE | A*11:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| VVGADGVGK | 8-16 | ４°C | |||||
|
|
TC-8001-2 |
HLA-A*11:01 KRAS7-16 G12D Tetramer-VVVGADGVGK-APC |
|
||||
|
|
cancer | APC | A*11:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| VVVGADGVGK | 7-16 | ４°C | |||||
|
|
TS-M255-1 |
HLA-A*03:01 ATR Neoepitope Tetramer-KLYEEPLLK-PE |
|
||||
|
|
cancer | PE | A*03:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| KLYEEPLLK | ４°C | ||||||
|
|
TS-M247-2 |
HLA-A*02:01 AGMO Neoepitope Tetramer-ALLQVTLLL-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| ALLQVTLLL | ４°C | ||||||
|
|
TC-8026-2 |
HLA-A*24:02 NY-ESO-1158-166 Tetramer-LLMWITQCF-APC |
|
||||
|
|
cancer | APC | A*24:02 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| LLMWITQCF | 158-166 | ４°C | |||||
|
|
TC-8003-1 |
HLA-A*11:01 KRAS7-16 G12V Tetramer-VVVGAVGVGK-PE |
|
||||
|
|
cancer | PE | A*11:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| VVVGAVGVGK | 7-16 | ４°C | |||||
|
|
TC-8030-1 |
HLA-A*03:01 KRAS7-16 G12C Tetramer-VVVGACGVGK-PE |
|
||||
|
|
cancer | PE | A*03:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| VVVGACGVGK | 7-16 | ４°C | |||||
|
|
TC-8026-1 |
HLA-A*24:02 NY-ESO-1158-166 Tetramer-LLMWITQCF-PE |
|
||||
|
|
cancer | PE | A*24:02 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| LLMWITQCF | 158-166 | ４°C | |||||
|
|
TS-M274-1 |
HLA-B*07:02 Filamin A Neoepitope Tetramer-CVRVSGQGL-PE |
|
||||
|
|
cancer | PE | B*07:02 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| CVRVSGQGL | ４°C | ||||||
|
|
TC-8033-1 |
HLA-A*03:01 KRAS8-16 WT Tetramer-VVGAGGVGK-PE |
|
||||
|
|
cancer | PE | A*03:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| VVGAGGVGK | 8-16 | ４°C | |||||
|
|
TS-M613-1 |
H-2Kb GLMP Tetramer-SALVFTRL-PE |
|
||||
|
|
cancer | PE | H-2Kb | 50 tests | ￥209,000 |
0 (Contact us) |
|
| SALVFTRL | 119-126 | ４°C | |||||
|
|
TS-M202-1 |
HLA-A*01:01 NRAS Neoepitope Tetramer-ILDTAGREEY-PE |
|
||||
|
|
cancer | PE | A*01:01 | 50 tests | ￥209,000 |
0 (Contact us) |
|
| ILDTAGREEY | ４°C | ||||||
- The availability is based on the information in Japan at 00:05, Sep 10, 2026 in JST.
- The special price is shown in red color.
- Please note that products cannot be ordered from this website. To purchase the items listed in this website, please contact us or local distributers.
- For storage temparature: RT: room temparature
- Please note that products in this website might be changed or discontinued without notification in advance for quality improvement.